VireturnRevenue
402.1B USDAnnual · FY 2025CVS
CVS HEALTH Corp
Operating income
4.7B USDAnnual · FY 2025Net income
1.8B USDAnnual · FY 2025Total assets
253.5B USDAnnual · FY 2025Equity
75.2B USDAnnual · FY 2025Operating cash flow
10.6B USDAnnual · FY 2025CVS · Chart
Chart provided by TradingView. Loading the chart connects your browser to TradingView and sends necessary technical information such as your IP address, page URL, and displayed symbol.
Reported financial information
Revenue
USD
402.1B USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 292.1B USD |
| FY 2022 | 322.5B USD |
| FY 2023 | 357.8B USD |
| FY 2024 | 372.8B USD |
| FY 2025 | 402.1B USD |
Operating income
USD
4.7B USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 13.3B USD |
| FY 2022 | 8B USD |
| FY 2023 | 13.7B USD |
| FY 2024 | 8.5B USD |
| FY 2025 | 4.7B USD |
Net income
USD
1.8B USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 8B USD |
| FY 2022 | 4.3B USD |
| FY 2023 | 8.3B USD |
| FY 2024 | 4.6B USD |
| FY 2025 | 1.8B USD |
Total assets
USD
253.5B USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 233B USD |
| FY 2022 | 228.3B USD |
| FY 2023 | 249.7B USD |
| FY 2024 | 253.2B USD |
| FY 2025 | 253.5B USD |
Equity
USD
75.2B USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 74.8B USD |
| FY 2022 | 71.8B USD |
| FY 2023 | 76.6B USD |
| FY 2024 | 75.6B USD |
| FY 2025 | 75.2B USD |
Operating cash flow
USD
10.6B USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 18.3B USD |
| FY 2022 | 16.2B USD |
| FY 2023 | 13.4B USD |
| FY 2024 | 9.1B USD |
| FY 2025 | 10.6B USD |
Revenue growth
%
7.8%
Period data
| Period | Value |
|---|---|
| FY 2021 | 8.7% |
| FY 2022 | 10.4% |
| FY 2023 | 10.9% |
| FY 2024 | 4.2% |
| FY 2025 | 7.8% |
Operating income growth
%
-45.3%
Period data
| Period | Value |
|---|---|
| FY 2021 | -4.3% |
| FY 2022 | -40.2% |
| FY 2023 | 72.8% |
| FY 2024 | -38% |
| FY 2025 | -45.3% |
Net income growth
%
-61.7%
Period data
| Period | Value |
|---|---|
| FY 2021 | 11.5% |
| FY 2022 | -46.1% |
| FY 2023 | 93.6% |
| FY 2024 | -44.7% |
| FY 2025 | -61.7% |
Operating margin
%
1.2%
Period data
| Period | Value |
|---|---|
| FY 2021 | 4.6% |
| FY 2022 | 2.5% |
| FY 2023 | 3.8% |
| FY 2024 | 2.3% |
| FY 2025 | 1.2% |
Net margin
%
0.4%
Period data
| Period | Value |
|---|---|
| FY 2021 | 2.7% |
| FY 2022 | 1.3% |
| FY 2023 | 2.3% |
| FY 2024 | 1.2% |
| FY 2025 | 0.4% |
Return on assets
%
0.7%
Period data
| Period | Value |
|---|---|
| FY 2021 | 3.5% |
| FY 2022 | 1.9% |
| FY 2023 | 3.5% |
| FY 2024 | 1.8% |
| FY 2025 | 0.7% |
Debt/Equity
x
2.37x
Period data
| Period | Value |
|---|---|
| FY 2021 | 2.11x |
| FY 2022 | 2.18x |
| FY 2023 | 2.26x |
| FY 2024 | 2.35x |
| FY 2025 | 2.37x |